Proof-of-concept trial to evaluate the pharmacokinetics of a controlled-release pravastatin formulation [CRES; controlle-release enhanced statin] versus a conventional pravastatin formulation [Pravachol] in volunteers.

Trial Profile

Proof-of-concept trial to evaluate the pharmacokinetics of a controlled-release pravastatin formulation [CRES; controlle-release enhanced statin] versus a conventional pravastatin formulation [Pravachol] in volunteers.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 26 May 2009

At a glance

  • Drugs Pravastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top